Summary & Overview
HCPCS G2159: Pneumococcal Vaccine Status or Prior Vaccine Reaction
HCPCS Level II code G2159 documents patients who either did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart (with the first dose administered after age 60) or who have a prior pneumococcal vaccine adverse reaction. The code captures important preventive care and safety exceptions relevant to adult immunization quality measures and can affect reporting and population health assessments nationally. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context for G2159, including which patient scenarios the code represents, the typical service type (vaccination status assessment and documentation), and common sites of service (outpatient and ambulatory care). The publication provides benchmarks and coding considerations, summarizes policy implications for immunization quality measurement, and outlines how G2159 interacts with national adult immunization efforts. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes are noted as unavailable in the input.
Billing Code Overview
HCPCS Level II code G2159 indicates that a patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period; or the patient has a prior pneumococcal vaccine adverse reaction any time during or before the measurement period.
-
Service type: Vaccination history assessment and documentation related to pneumococcal immunization status
-
Typical site of service: Outpatient clinical settings, primary care offices, and other ambulatory care sites where preventive immunization status is evaluated
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a primary care clinic for an annual wellness visit. Their immunization record documents receipt of the 13-valent pneumococcal conjugate vaccine (PCV13) at age 61 but no subsequent pneumococcal polysaccharide vaccine (PPSV23) administered at least 12 months later. The clinician reviews prior vaccine history, documents the interval since PCV13, confirms there is no documented pneumococcal vaccine adverse reaction, and determines the patient is eligible for PPSV23. During the visit the clinician counsels the patient, documents the discussion and informed refusal if the patient declines, and either administers PPSV23 or documents the reason for not administering it (previous adverse reaction, medical contraindication, or patient refusal). Coding for this scenario uses G2159 when the patient did not receive both vaccines at least 12 months apart (first occurrence after age 60) or has a prior pneumococcal vaccine adverse reaction. Typical workflow steps include reviewing immunization history, assessing contraindications/allergies, shared decision-making, vaccine administration or documented refusal/contraindication, and coding/billing per payor rules. Typical sites of service are ambulatory primary care clinics, outpatient preventive care visits, and community vaccination clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |